DIETary Intake, Death and Hospitalization in Adult With End-stage Kidney Disease Treated With HemoDialysis (DIET-HD) Study
1 other identifier
observational
9,757
0 countries
N/A
Brief Summary
The DIETary intake, death and hospitalisation in adults with end-stage kidney disease treated with HaemoDialysis (DIET-HD) study is a multinational prospective cohort study designed to evaluate the association between nutrition and dietary patterns and health outcomes in prevalent adult haemodialysis patients in Europe and South America.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2014
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 5, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2016
CompletedFirst Submitted
Initial submission to the registry
April 18, 2017
CompletedFirst Posted
Study publicly available on registry
April 24, 2017
CompletedApril 24, 2017
April 1, 2017
2.1 years
April 18, 2017
April 20, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cardiovascular mortality
Defined as sudden death or death attributed to acute myocardial infarction, pericarditis, atherosclerotic heart disease, cardiomyopathy, cardiac arrhythmia, cardiac arrest, valvular heart disease, pulmonary edema, or congestive cardiac failure
12 months since baseline dietary evaluation
Secondary Outcomes (3)
All-cause mortality
12 months since baseline dietary evaluation
Infection-related mortality
12 months since baseline dietary evaluation
All-cause and cardiovascular related hospitalisation
12 months since baseline dietary evaluation
Interventions
Eligibility Criteria
dialysis clinics administered by a single dialysis provider
You may qualify if:
- End-stage kidney disease
- Long-term haemodialysis for at least the previous 90 days
- years or older
- Treating team agrees to the patient's involvement in the study
- Participant willing to provide written and informed consent.-
You may not qualify if:
- significant neurocognitive disability or medical comorbidity that would preclude them from understanding the dietary questionnaire even if assisted
- a life expectancy less than 6 months according to their treating physician
- planned kidney transplantation within 6 months of baseline
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Giovanni Strippolilead
- University of Sydneycollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
Giovanni FM Strippoli, MD, PhD
University of Bari
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
April 18, 2017
First Posted
April 24, 2017
Study Start
January 5, 2014
Primary Completion
January 31, 2016
Study Completion
January 31, 2016
Last Updated
April 24, 2017
Record last verified: 2017-04